Beta-2 microglobulin and all-cause mortality in the era of high-flux hemodialysis: results from the Dialysis Outcomes and Practice Patterns Study

BACKGROUND: Beta-2 microglobulin (β2M) accumulates in hemodialysis (HD) patients, but its consequences are controversial, particularly in the current era of high-flux dialyzers. High-flux HD treatment improves β2M removal, yet β2M and other middle molecules may still contribute to adverse events. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanda, Eiichiro, Muenz, Daniel, Bieber, Brian, Cases, Aleix, Locatelli, Francesco, Port, Friedrich K, Pecoits-Filho, Roberto, Robinson, Bruce M, Perl, Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087125/
https://www.ncbi.nlm.nih.gov/pubmed/33959272
http://dx.doi.org/10.1093/ckj/sfaa155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087125/
https://www.ncbi.nlm.nih.gov/pubmed/33959272
http://dx.doi.org/10.1093/ckj/sfaa155

Ejemplares similares